This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
Primary Care Telehealth Interventions for COPD

Primary Care Telehealth Interventions for COPD

Format

Webcast

Time to Complete

2.25 hours

Released

December 31, 2018

Expires

December 31, 2019
Add to Queue


Maximum Credits

2.25 / AMA PRA Category 1 CreditTM
2.30 / CNE Contact Hours
2.25 / CE for Pharmacists (0.225 CEUs)

Accredited Provider



Jointly provided by Postgraduate Insitute for Medicine and Telebehavioral Health Insitute

Commercial Supporter

Supported by an educational grant from Glaxo Smith Kline

Program Description

Program consists of five 20-30 minute discussions between a leading telepulmonary researcher and a telehealth trainer to bring to illustrate evidence-based treatment protocols used by primary care physicians and telepulmonologists for treating COPD with telehealth. It includes foundational terms and concepts, common patient concerns, pivotal studies, important steps to getting started such as how to select technology vendors, patient screening, involving family and friends; staffing; documentation; billing and coding, as well as legal and regulatory compliance. Case-based examples are drawn upon to illustrate pivotal decision points. Slides, transcripts, recordings and other resources are available for immediate access.

Intended Audience

The intended audience for this chronic obstructive pulmonary disease (COPD) telehealth and remote patient monitoring (RPM) intervention are primary care providers (PCPs) and their support professionals (registered nurses, physician’s assistants, nurse practitioners and pharmacists) who deliver integrated care to COPD patients.

Educational Objectives

After completing this activity, participants should be better able to:

  • Evaluate telehealth strategies to support patient engagement with remote COPD patient monitoring.
  • Discuss how to educate COPD patients with mood disorders and other psychiatric conditions using telehealth strategies.
  • Identify interventions that can be utilized for COPD patients receiving telehealth services.

Module Titles

I. What are telehealth interventions for COPD patients?
II. Current technologies available for telehealth treatment of COPD
III. Telehealth Implementation for COPD patients
IV. Essential Telepractice PRotocols - HIPAA, CPT or HCPCS Billing Codes and More
V. Data Collection Processes: How to Integrate PCP and Specialist Offices

Conflicts of Interest Disclosure Policy

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty

Marlene M. Maheu, PhD
Executive Director
Telebehavioral Health Institute

Dr. Maheu has nothing to disclose

Shereen Nabhani-Gebara, PharmD, BCOP
Senior Lecturer in Pharmacy
Kingston University London

Dr. Nabhani-Gebara has nothing to disclose

Accredited Provider Disclosures

The PIM planners and managers have nothing to disclose. The Telebehavioral Health Institute planners and managers have nothing to disclose.

Credit

2.25

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Telebehaviorial Health Institute. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credit(s)TM .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

2.30

Type

CNE Contact Hour(s)

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Telebehaviorial Health Institute. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

The maximum number of hours awarded for this Continuing Nursing Education activity is 2.30 contact hours.

Credit

2.25

Type

CE for Pharmacists

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Telebehaviorial Health Institute. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

Postgraduate Institute for Medicine designates this continuing education activity for 2.25 contact hour(s) (0.225 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number – JA4008162-9999-18-441-H01-P
Type of Activity (select one): Application

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Fee Information

There is no fee for this course.

Instructions

To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

If you have any questions relating to the accreditation of this activity, please contact Postgraduate Institute for Medicine at: inquiries@pimed.com or (303) 799-1930.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue